|
|
|
Insider
Information: |
Powell Michael |
Relationship: |
10% Owner |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
21 |
|
Direct
Shares |
22,645,475 |
|
Indirect Shares
|
6,181,468 |
|
|
Direct
Value |
$15,689,187 |
|
|
Indirect Value
|
$148,316,858 |
|
|
Total
Shares |
28,826,943 |
|
|
Total
Value |
$164,006,045 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
Percentage
Gain/Loss : |
-63.7%
|
32.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seagen Inc |
SGEN |
Director |
2004-12-16 |
20,001 |
2004-12-16 |
647,577 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
Director |
2005-03-08 |
3,440,201 |
2006-03-16 |
12,846 |
Premium* |
|
Anesiva Inc |
ANSVQ |
Director, 10% Owner |
2007-12-18 |
65 |
2007-12-18 |
4,906,973 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-09 |
43,213 |
|
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
Director |
2010-12-23 |
1 |
2010-12-23 |
0 |
Premium* |
|
Trius Therapeutics Inc |
TSRX |
Director |
2010-08-06 |
0 |
2012-03-26 |
9,302 |
Premium* |
|
Humanigen Inc |
HGEN |
10% Owner |
2013-02-05 |
414,394 |
2013-02-05 |
0 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
Director |
2016-07-29 |
0 |
2016-10-31 |
14,328 |
Premium* |
|
Aravive Inc |
ARAV |
10% Owner |
2014-03-26 |
2,146,978 |
2014-03-26 |
0 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2015-05-07 |
0 |
2014-06-04 |
0 |
Premium* |
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2014-07-10 |
0 |
2014-07-09 |
0 |
Premium* |
|
Marinus Pharmaceuticals Inc |
MRNS |
10% Owner |
2014-08-05 |
0 |
2016-10-20 |
15,470 |
Premium* |
|
Synlogic Inc |
SYBX |
Director |
2015-10-05 |
0 |
2018-01-26 |
574,972 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-13 |
2,289,480 |
2015-10-13 |
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
1,180,178 |
2018-09-28 |
0 |
Premium* |
|
Nextcure, Inc. |
NXTC |
10% Owner |
2019-11-15 |
2,671,856 |
2019-11-15 |
0 |
Premium* |
|
Iterum Therapeutics Plc |
ITRM |
10% Owner |
2020-06-02 |
1,226,514 |
2020-06-01 |
0 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
1,515,073 |
2020-06-30 |
0 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
2,028,308 |
2020-07-28 |
0 |
Premium* |
|
Bolt Biotherapeutics, Inc. |
BOLT |
10% Owner |
2021-02-09 |
2,754,437 |
2021-02-09 |
0 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
10% Owner |
2021-05-18 |
2,914,776 |
2021-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
126 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2004-06-21 |
4 |
S |
$7.16 |
$251,735 |
I/I |
(35,000) |
1,685,285 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-09-21 |
4 |
S |
$6.70 |
$259,005 |
I/I |
(38,500) |
1,193,589 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-12-14 |
4 |
S |
$7.00 |
$280,000 |
I/I |
(40,000) |
663,623 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2003-12-02 |
4 |
S |
$6.35 |
$321,540 |
I/I |
(50,000) |
1,949,176 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-06-25 |
4 |
S |
$7.02 |
$330,660 |
I/I |
(47,000) |
1,532,506 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-09-29 |
4 |
S |
$6.65 |
$333,730 |
I/I |
(50,000) |
1,080,763 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2003-11-24 |
4 |
S |
$6.25 |
$344,500 |
I/I |
(55,000) |
2,149,997 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2003-12-08 |
4 |
S |
$7.00 |
$351,450 |
I/I |
(50,000) |
1,889,170 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-11-12 |
4 |
S |
$6.70 |
$362,350 |
I/I |
(54,000) |
1,026,805 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-11-16 |
4 |
S |
$6.90 |
$372,845 |
I/I |
(54,000) |
887,251 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-09-23 |
4 |
S |
$6.75 |
$385,918 |
I/I |
(55,988) |
1,139,113 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-06-23 |
4 |
S |
$7.05 |
$409,880 |
I/I |
(57,500) |
1,594,745 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-12-02 |
4 |
S |
$6.91 |
$414,999 |
I/I |
(59,300) |
797,975 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2003-12-01 |
4 |
S |
$6.25 |
$418,004 |
I/I |
(66,500) |
1,997,801 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-12-03 |
4 |
S |
$7.00 |
$482,525 |
I/I |
(68,200) |
731,650 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-23 |
4 |
S |
$6.75 |
$489,500 |
I/I |
(72,000) |
1,374,474 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-03-08 |
4 |
S |
$10.33 |
$521,988 |
I/I |
(50,000) |
1,743,052 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-11-15 |
4 |
S |
$6.70 |
$609,619 |
I/I |
(89,500) |
939,766 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2003-12-23 |
4 |
S |
$7.10 |
$629,593 |
I/I |
(87,250) |
1,798,485 |
|
- |
|
ITRM |
Iterum Therapeutics Plc |
10% Owner |
|
2020-06-02 |
4 |
S |
$1.61 |
$642,960 |
D/D |
(400,000) |
1,226,514 |
0 |
% |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2010-03-17 |
4 |
S |
$6.29 |
$955,472 |
I/I |
(152,000) |
20,553 |
0 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2020-06-30 |
4 |
B |
$17.00 |
$999,991 |
D/D |
58,823 |
1,515,073 |
2.45 |
- |
|
MRNS |
Marinus Pharmaceuticals I... |
10% Owner |
|
2016-10-20 |
4 |
S |
$1.39 |
$1,042,699 |
I/I |
(750,683) |
15,470 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2010-12-17 |
4 |
S |
$8.76 |
$1,149,575 |
I/I |
(131,254) |
12,945 |
0 |
- |
|
ARAV |
Aravive Inc |
10% Owner |
|
2014-03-26 |
4 |
B |
$21.00 |
$1,260,000 |
D/D |
60,000 |
2,146,978 |
2.45 |
- |
|
126 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|